A UVA Engineering alumnus, Kevin Eisenfrats, has advanced to the national finals in a “Shark Tank”-style competition for his team’s invention of a non-surgical contraceptive for men, Contraline.
The final round of the inaugural Atlantic Coast Conference InVenture Prize will be held tonight (April 6, 2016) on the campus of the Georgia Institute of Technology, and the finals will be streamed live at 8 p.m. EST at http://www.gpb.org/acc-inventure-2016.
Contraline is one of five finalist teams from ACC universities that will pitch their ideas before a live audience and a panel of judges. They are competing for a $30,000 prize. A preliminary round took place April 5.
According to the ACC InVenture Prize Web site, “The ACC InVenture Prize is a collaborative effort by institutional leadership from the Atlantic Coast Conference (ACC). It represents an opportunity to stimulate undergraduate entrepreneurial activity and increase student-faculty engagement, to celebrate and highlight the exceptional creativity and ingenuity of our students, and to inspire a greater sense of camaraderie across the conference.”
Eisenfrats, who graduated from the UVA School of Engineering and Applied Science in 2015 with a degree in nanomedicine engineering and minors in chemistry and biomedical engineering, led a team of engineering and UVA medical students that developed Contraline, which is a polymer injection for men that has been characterized as a non-surgical, easily reversible vasectomy.
The Contraline concept won the $20,000 first prize in UVA’s 2014 Entrepreneurship Cup and the $10,000 first prize in UVA’s 2015 Darden Business Plan competition. Contraline also was a finalist in the prestigious Collegiate Inventors Competition last fall.